Latest news with #AgamVora
Time of India
3 days ago
- Health
- Time of India
Stay strong this monsoon: Why adults need a yearly shot too!
This summer, the month of May brought a surprise downpour—India saw its heaviest rainfall since 1901. Monsoon weather can be a real rollercoaster, one moment it's overcast with cloudy skies and cool breezes, and the next, the sun is blazing. These sudden shifts in temperature, along with rising humidity, can take a toll on your immune system, making it easier for seasonal bugs like the flu to spread. Tropical countries like India experience a high frequency of flu (or influenza) cases during this time. Flu viruses like A(H1N1), A(H3N2), and Influenza B don't take a break—they circulate all year long. That's why getting your annual flu shot is one of the best ways to stay protected, no matter the season. According to Dr Agam Vora, General Secretary for the Association of Physicians of India, Medical Director, Vora Clinic, Mumbai, 'A lot of people mix up the flu with a regular cold—but the flu is much more serious. While both can cause symptoms like a sore throat or cough, the flu often comes with a high fever, body aches, headaches and nausea4. Spotting these symptoms early can help you recover faster and avoid complications. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like They Were So Beautiful Before; Now Look At Them; Number 10 Will Shock You Reportingly Undo And since flu viruses keep changing every year, the vaccine is updated regularly—so getting your flu shot annually is the best way to stay protected. ' To protect against the flu this monsoon, here are 3 steps you can take: 1. Wash your hands often with soap and water or use a hand sanitizer when you're on the go. Try not to touch your face—especially your eyes, nose, or mouth—and don't forget to clean things you touch a lot, like your phone or doorknobs 2. Try to keep your distance from anyone who's feeling under the weather. Let fresh air in by opening windows when you can, and don't forget to wear a mask in crowded places 3. Make sure you and your family follow all the steps to be protected—keep up with your child's vaccination schedule along with your own and any adults living in your household. Since flu viruses keep changing, the vaccine is updated every year based on the latest strains identified by the World Health Organization (WHO). That's why getting vaccinated every year is so important Dr Jejoe Karankumar, Medical Affairs Director, Abbott India said, 'Vaccines aren't just for kids—adults need protection too, especially from infections like the flu. Getting a flu shot every year doesn't just lower your chances of getting sick, it also helps reduce the severity of symptoms if you do catch it. It's a simple step in preventive care that can make a big difference, especially for elderly or people with comorbidities.' Even if you're healthy, the flu can still slow you down—with missed work, doctor visits, and sudden health expenses. That's why the World Health Organization recommends getting a flu shot every year. It works well for all age groups—including pregnant women and people with health conditions—and helps protect you from serious illness. While we can't control the weather, we can take charge of our health. An annual flu shot is a simple, science-backed step that protects not just you, but those around you—especially the elderly, young children, and people with chronic conditions. So this monsoon, don't wait for symptoms to strike. Talk to your doctor about getting your flu vaccine. Because staying healthy isn't just about reacting to illness—it's about preventing it.
Time of India
18-07-2025
- Health
- Time of India
Kenvue ties up with API to launch India's first Cough Clinics
Kenvue , a consumer health company and makers of Benadryl cough syrup , on Friday announced the launch of ' Cough Clinics ', an industry-first initiative, in association with the Association of Physicians of India (API). As part of this scientific initiative, Kenvue plans to establish 10 Cough Centres of Excellence across India. These centres will run 'Cough Clinics' with an aim to scale knowledge on scientific best practices around cough evaluation and expand its usage in treatment, said Kenvue in a statement. Explore courses from Top Institutes in Select a Course Category Technology Digital Marketing MCA Degree Data Science Operations Management Product Management Project Management Artificial Intelligence Management CXO MBA Design Thinking Cybersecurity others Healthcare Finance healthcare Leadership Others PGDM Public Policy Data Analytics Data Science Skills you'll gain: Duration: 12 Weeks MIT xPRO CERT-MIT XPRO Building AI Prod India Starts on undefined Get Details "We are working with health care professionals to raise awareness of non-bronchodilator formulations for productive cough since there is enough evidence to show that not all productive coughs need a bronchodilator," said Prashant Shinde, Business Unit Head, Self-Care, Kenvue India. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Would you like to know more? Undo In India, the average adult experiences about three episodes of cough per year, while children may experience 7-10 episodes per year, according to experts. However, cough syrup formulations have been under the scanner in recent times due to the lack of therapeutic justification behind some of the prevalent formulations in the market. Live Events Despite high occurrences of coughs and respiratory illnesses , 70 per cent of individuals receive experience-based therapy without a confirmed diagnosis as confirmed in an article published in Journal of Association of Physicians of India. The absence of a systematic approach has often led to the use of multi-ingredient irrational cough formulations, increasing the risk of side effects and escalating treatment costs especially in vulnerable sections of the population including elderly and children. With an aim to address this gap, 'Cough Clinics' by Kenvue and API seek to redefine cough evaluation and management by equipping health care professionals with a simplified, science-backed approach rooted in symptom categorization. Agam Vora, General Secretary, API, said, "Despite the high burden of cough-related consultations in India, standardized diagnostic tools have largely been missing in primary care, leading to overdependence on empirical treatment and missed opportunities for early intervention. "We are delighted to launch India's first ever Cough Clinics in association with Kenvue to offer physicians in primary care with specialized training and tools to understand different types of coughs and improve patient care." The Cough Clinics will comprise three learning modules. Each module is designed to focus on specific aspects of cough evaluation, sound recognition, treatment decision-making, and rational treatment. The content has been curated and validated by experts from the Association of Physicians of India (API), and each session will be anchored by leading Pulmonologists, the statement said. Every participating physician will undergo a thorough assessment to measure the knowledge shift as well as a Net Promoter Score will be collected to evaluate experience and effectiveness, it stated.
News18
18-07-2025
- Health
- News18
Kenvue ties up with API to launch Indias first Cough Clinics
New Delhi, Jul 18 (PTI) Kenvue, a consumer health company and makers of Benadryl cough syrup, on Friday announced the launch of 'Cough Clinics', an industry-first initiative, in association with the Association of Physicians of India (API). As part of this scientific initiative, Kenvue plans to establish 10 Cough Centres of Excellence across India. These centres will run 'Cough Clinics' with an aim to scale knowledge on scientific best practices around cough evaluation and expand its usage in treatment, said Kenvue in a statement. 'We are working with health care professionals to raise awareness of non-bronchodilator formulations for productive cough since there is enough evidence to show that not all productive coughs need a bronchodilator," said Prashant Shinde, Business Unit Head, Self-Care, Kenvue India. In India, the average adult experiences about three episodes of cough per year, while children may experience 7-10 episodes per year, according to experts. However, cough syrup formulations have been under the scanner in recent times due to the lack of therapeutic justification behind some of the prevalent formulations in the market. Despite high occurrences of coughs and respiratory illnesses, 70 per cent of individuals receive experience-based therapy without a confirmed diagnosis as confirmed in an article published in Journal of Association of Physicians of India. The absence of a systematic approach has often led to the use of multi-ingredient irrational cough formulations, increasing the risk of side effects and escalating treatment costs especially in vulnerable sections of the population including elderly and children. With an aim to address this gap, 'Cough Clinics' by Kenvue and API seek to redefine cough evaluation and management by equipping health care professionals with a simplified, science-backed approach rooted in symptom categorization. Agam Vora, General Secretary, API, said, 'Despite the high burden of cough-related consultations in India, standardized diagnostic tools have largely been missing in primary care, leading to overdependence on empirical treatment and missed opportunities for early intervention. 'We are delighted to launch India's first ever Cough Clinics in association with Kenvue to offer physicians in primary care with specialized training and tools to understand different types of coughs and improve patient care." The Cough Clinics will comprise three learning modules. Each module is designed to focus on specific aspects of cough evaluation, sound recognition, treatment decision-making, and rational treatment. The content has been curated and validated by experts from the Association of Physicians of India (API), and each session will be anchored by leading Pulmonologists, the statement said. Every participating physician will undergo a thorough assessment to measure the knowledge shift as well as a Net Promoter Score will be collected to evaluate experience and effectiveness, it stated. PTI PLB DRR view comments First Published: July 18, 2025, 13:30 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
The Hindu
17-07-2025
- Health
- The Hindu
Kenvue ties up with API to launch ‘Cough Clinics' to train Drs
With the duration and frequency of cough episodes increasing among Indians since the onset of COVID-19, Kenvue, the world's largest consumer health company by revenue and makers of Benadryl cough syrup, has announced 'Cough Clinics', an industry-first initiative in association with the Association of Physicians of India (API). As part of this scientific initiative, Kenvue would establish 10 Cough Centres of Excellence across India where over 1,000 doctors would be trained in one year for effective diagnosis of cough and prescribe the right medicine. The first Cough Centre of Excellence has been launched in Mumbai at BSES Hospital, Andheri. Prashant Shinde, Business Unit Head, Self-Care, Kenvue India, said, 'Benadryl, has been trusted by doctors for over 50 years. We continue working closely with health care professionals to advance the science behind cough and bring the most targeted solutions to deliver superior treatment outcomes.' 'Through our collaboration with API as we will jointly simplify cough management. This initiative will help provide crucial clinical training to healthcare professionals and equip them to follow evidence-based management strategies in cough.' Dr. Agam Vora, Hon. General Secretary, API, said, 'Despite the high burden of cough-related consultations in India, standardized diagnostic tools have largely been missing in primary care, leading to overdependence on empirical treatment and missed opportunities for early intervention.' 'The Cough Clinics will offer physicians in primary care with specialized training and tools to understand different types of coughs and improve patient care,' he said. The Cough Clinics will comprise of three learning modules. Each module is designed to focus on specific aspects of cough evaluation, sound recognition, treatment decision-making, and rational treatment. The content has been curated and validated by experts from the Association of Physicians of India (API), and each session will be anchored by leading Pulmonologists. Every participating physician will undergo a thorough assessment to measure the knowledge shift as well as a Net Promoter Score (NPS) will be collected to evaluate experience and effectiveness. Following the Mumbai launch, the initiative will roll out in key cities including Lucknow, Chandigarh, Hyderabad, Bengaluru, Chennai and Kolkata in the coming months. In India, the average adult experiences about three episodes of cough per year while children may experience 7-10 episodes per year. Cough is one of the most common symptoms treated by primary care physicians. However, cough syrup formulations have been under the scanner in recent times due to the lack of therapeutic justification behind some of the prevalent formulations in the market. Despite high occurrence of coughs and respiratory illnesses, 70% individuals receive experience-based therapy without a confirmed diagnosis. The absence of a systematic approach has often led to the use of multi-ingredient irrational cough formulations, increasing the risk of side effects and escalating treatment costs especially in vulnerable sections of population including elderly and children.
Time of India
19-06-2025
- Health
- Time of India
Silent Signals: Uncovering Impact of Angina on Women in India
New Delhi: While women face many health challenges throughout their lives, heart disease stands out as one of the most serious — causing more deaths and disability than any other condition worldwide. A 2016 report by the India n Council of Medical Research identified heart disease as the leading cause of illness in India. According to the National Family Health Survey (2019–20), about 0.7% of women and 0.9% of men in India report having heart disease. India's death rate from heart disease already exceeds the global average — and studies show that women may be even more at risk. Conditions like angina often present subtly, with symptoms that are easy to miss but can lead to higher risks. To spotlight this critical issue, ETHealthworld, in collaboration with global healthcare leader Abbott , hosted a webinar titled Her Heart Matters: Understanding Angina and Coronary Artery Disease in Women. The session brought together medical experts to explore the unique cardiovascular challenges faced by Indian women. The expert panel featured Dr Jyotirmoy Pal President, Association of Physicians of India (API); Dr Agam Vora , Honorary General Secretary, Association of Physicians of India (API); Dr. Gurpreet S Wander, Chief Cardiologist, Hero DMC Heart Institute, Ludhiana; Dr. Sarita Rao, Senior Interventional Cardiologist and Director Cath Lab, Apollo Hospitals, Indore; Dr Rohita Shetty Head of Medical Affairs, Abbott India. The discussion was moderated by Prathiba Raju, Senior Assistant Editor, ET Healthworld. Exploring the underlying causes of angina, Dr Jyotirmoy Pal explained that while non-communicable diseases (NCDs) accounted for a third of deaths at the time of India's independence, decades of lifestyle and metabolic shifts have dramatically altered the landscape— with cardiovascular diseases now emerging as the leading cause of mortality. Angina, commonly experienced as chest pain, is one of the most recognizable early warning signs of heart disease. Dr. Gurpreet S. Wander added that approximately 60–65% of individuals with coronary artery disease report experiencing angina symptoms. Discussing key risk factors for angina, Dr. Wander emphasized that among the eight major contributors to heart disease — including high blood pressure, diabetes, obesity, and stress — genetics and lifestyle choices, particularly tobacco use, pose the greatest risk for individuals under 60. He also noted that while women benefit from a degree of natural protection against heart disease due to hormonal factors, this advantage is significantly diminished in the presence of diabetes. Experts further highlighted a critical gap in research: women comprise only about 20% of participants in heart disease clinical trials. As a result, most treatment protocols are based predominantly on male-centric data, making it more challenging to develop care strategies tailored specifically to women's cardiovascular health. Diagnosis Dilemma Speaking on the importance of early detection, Dr. Jyotirmoy Pal emphasized that recognizing angina symptoms promptly can lead to timely intervention — potentially saving lives. However, in India, recurring chest pain is often misdiagnosed as Acid Peptic Disorder (APD), delaying appropriate cardiac care. Dr. Agam Vora added that there's a common misconception that only individuals with conditions like diabetes or obesity are at risk for angina. 'That's not always the case,' he noted, stressing the need for clinicians to adopt modern diagnostic tools — especially when interpreting ECG results proves challenging. Dr. Wander further explained that angina can sometimes present with symptoms like burping, which are frequently mistaken for acidity. 'If the discomfort isn't localized and lasts for 3 to 5 minutes, it could be a sign of heart-related chest pain,' he cautioned. The panel also underscored the value of non-invasive diagnostic tests — such as treadmill tests, stress echocardiography, and cardiac imaging — in identifying angina early. These tools can help avoid diagnostic delays, which is critical, as untreated angina can escalate into a heart attack , posing serious, potentially life-threatening risks. Gender-Based Differences Dr. Rao explained that heart disease symptoms in women can be quite different from those in men. Instead of the typical chest pain, women may feel breathless, break into a sweat, or experience symptoms like acidity, heartburn, or even nausea. She also noted that diagnosing heart issues in women can be more complex. For example, their ECGs may show subtle changes, and they're more likely to test positive during a treadmill test. Women also experience a type of heart condition called microvascular angina, which affects the smaller blood vessels and often doesn't show up on standard heart scans like a coronary angiogram. While women do have some natural hormonal protection against heart disease, Dr. Rao pointed out that they also face unique risks — especially during and after pregnancy. Conditions like gestational diabetes and high blood pressure can increase a woman's chances of developing heart disease later in life. She also highlighted that early menopause, Polycystic Ovarian Disease (PCOD), and autoimmune disorders can raise the risk of heart problems even further. That's why it's important for women to stay informed and proactive about their heart health. Solutions to change the course Coronary artery disease (CAD) ranks among the leading causes of death from non-communicable diseases. While it is often diagnosed later in life, Dr. Wander emphasized that its origins can be traced back much earlier. Adopting healthy lifestyle habits early — and maintaining them consistently — plays a crucial role in preventing or delaying the onset of heart disease. Dr. Rao emphasized that regularly checking your blood pressure, cholesterol, and blood sugar — along with living a healthy lifestyle — can greatly reduce your risk of heart disease. Avoiding smoking and alcohol also plays a big role. These simple habits can help you stay healthier and be better prepared for any future health risks. Abbott's Efforts for Better Heart Health Dr. Rohita Shetty shared some of the steps Abbott is taking to support women's heart health, especially around angina. As part of its 2030 global goals, Abbott is working to fight non-communicable diseases like diabetes and heart conditions. Because angina often shows up differently in women and can be hard to recognize, there's a strong need to raise awareness. To help close this gap, Abbott collaborated with the Association of Physicians of India (API) to launch Angina Awareness Week in 2024. As part of this effort, Abbott introduced the OPTA (Optimal Treatment of Angina) initiative, which includes three helpful tools — a checklist, a questionnaire, and a clinical approach — all designed to improve how angina is diagnosed and managed. This year, the spotlight is on women — with a focus on improving their heart health and overall quality of life. Abbott's awareness initiatives aim to empower individuals with the knowledge they need to take control of their heart health and make informed choices for a healthier future. To summarize, with rising rates of obesity, hypertension, and hereditary risk factors, experts caution that the burden of heart disease is likely to continue growing. The good news is that this trend can be changed. By making healthier lifestyle choices, scheduling regular health checkups, and leveraging advanced diagnostic tools, individuals can take meaningful steps to reduce their risk — helping to build stronger, healthier families and communities. Disclaimer - The above content is non-editorial, and TIL hereby disclaims any and all warranties, expressed or implied, relating to it, and does not guarantee, vouch for or necessarily endorse any of the content.
